We have been engaged by our biopharmaceutical client to expand their existing MSL team for another launch set for 2020. This is yet another Rare Disease asset.
They currently have 3 marketed products and a very robust pipeline from Preclinical to Phase III.
This launch will be their 4th product to hit the market making a difference in the lives of patients.
The territories are listed below:
If you or a colleague have a minimum of 3 years MSL experience in Rare/Orphan Disease or Nephrology, contact Donna Gross at 267-483-5233 ext 101 or email@example.com.
The Bandish Group, LLC
Life Sciences Executive Search
1432 Easton Road, Suite 2B
Warrington, PA 18976